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Intraocular Pressure in Inbred
Mouse Strains
Simon W. M. John,* John R. Hagaman,^
Tammy E. MacTaggart,* Li Peng,^
and Oliver Smithesf
Purpose. To develop a protocol to measure the intraocu-
lar pressure (IOP) of living mice and to determine the
IOP of genetically different mouse strains.
Methods. Eyes of anesthetized animals were cannulated
with a very fine fluid-filled glass microneedle. The mi-
croneedle was connected to a pressure transducer, and
the pressure signal was analyzed with a computer sys-
tem. Intraocular pressures of male C3H/HeJ, C57BL/
6J, A/J, and BALB/cJ mice were determined.
Results. Differences in IOP were detected between ge-
netically distinct mouse strains maintained in virtually
identical environments. C3H/HeJ was the strain with
the highest average IOP (13.7 ± 0.8 mm Hg). This
strain average was 1.4 mm Hg higher than that for
C57BL/6J (12.3 ± 0.5 mm Hg; P = 0.14), 4.3 mm Hg
higher than that for A/J (9.4 ± 0.5 mm Hg; P< 0.001),
and 6 mm Hg higher than that for BALB/cJ (7.7 ± 0.5
mm Hg; P< 0.001).
Conclusions. The authors have developed an accurate
and reliable procedure for measuring intraocular pres-
sure in living mice. This procedure can detect IOP dif-
ferences between groups of mice that differ by geno-
type. Invest Ophthalmol Vis Sci. 1997;38:249-253.
VFlaucoma is a group of complex diseases involving
the death of retinal ganglion cells and the degenera-
tion of the optic nerve head. Glaucoma is the leading
cause of blindness in black Americans and the second
leading cause of blindness in the United States.1 It is
often associated with high intraocular pressure (IOP)
that results from an increased resistance to drainage
of the aqueous humor. Idiopathic or primary open-
angle glaucoma usually exhibits multifactorial inheri-
tance, and many studies indicate that relatives of pa-
tients with primary open-angle glaucoma have a
higher risk for the disease than the general popula-
tion. ' Two of the best-known risk factors for glaucoma,
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IOP and aqueous humor outflow, follow multifactorial
inheritance patterns.2
Glaucoma traditionally is viewed as a disease in
which deleteriously high IOP results in optic nerve
damage over time.1 Intraocular pressure, however, is
not the only factor. Nerve damage does not develop
in most persons who have high IOP for extended peri-
ods of time, but in others, nerve damage develops
despite IOP levels in the normal range.1 The factors
determining susceptibility of the retina and optic
nerve to glaucomatous damage are unknown. Some
studies implicate diabetes, vascular hypertension, arte-
rial hypotension, cardiovascular disease, sex, and race
in glaucomatous neuropathy. There are, however,
studies that find no association between the above
factors and glaucoma, and it is unclear which factors
actually interact with IOP to cause damage.3 The ge-
netic and pathophysiological basis of glaucoma is
poorly understood.
The ability to alter the mouse genome by adding
transgenes or altering endogenous genes makes mice
the most advanced mammalian system for assessing
the function of identified genes and for assessing the
consequences of mutating or overexpressing these
genes.4'5 The hundreds of inbred mouse strains, the
high density of genetic markers mapped on mouse
chromosomes, the ability to breed mice in the desired
fashion, and the ability to control environments make
the analysis of complex multifactorial traits more prac-
tical in mice than in any other mammal.4 We have
found no previous reports of IOP measurement in
mice. The development of an accurate and reliable
method to measure IOP in mice should facilitate
greatly the identification of genes involved in IOP reg-
ulation and the susceptibility of the retina and the
optic nerve to glaucomatous damage. We describe
here a procedure that allows the measurement of IOP
in mice.
MATERIALS AND METHODS. Animal Hus-
bandry and Experimental Design. All experiments
were performed in compliance with the ARVO State-
ment for the Use of Animals in Ophthalmic and Vision
Research. Male mice of strains C3H/HeJ (C3H),
C57BL/6J (B6), A/J, and BALB/cJ (BALB) were ob-
tained from the Jackson Laboratory (Bar Harbor,
ME). Mice of various genetic backgrounds were used
in the experiments to validate the measurement pro-
cedure and to test the effect of microneedle insertion
on IOP. Mice were received 3 weeks after birth and
were housed in adjacent cages covered loosely with
lexon filters and containing white pine bedding. The
environment was kept at 21°C with a 14-hour light-
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10-hour dark cycle. All mice were fed NIH31 (4% fat)
chow ad libitum. Animals ranged between 9 and 11
weeks of age at the time of IOP measurement. To
prevent differences caused by the time of measure-
ment, mice of different strains were intermixed during
all measurement periods.
Standardization of the Plane of Anesthesia. The
mice were anesthetized by intraperitoneal injection of
a mixture of ketamine (100 mg/kg) and xylazine (9
mg/kg). Anesthesia was administered to one mouse
at a time. Each mouse was monitored carefully to as-
sess the state of anesthesia. After the mouse lost con-
sciousness and failed to respond to touch, IOP was
measured as soon as possible (typically within 2 to 3
minutes of loss of consciousness). Then anesthesia was
injected and IOP was measured in the next mouse.
This protocol ensured IOP assessment of animals that
were in a similar plane of anesthesia and in a similar
physiologic state. In addition, it helped to control for
interindividual variability in the rate of metabolism
and susceptibility to the anesthetic agents and to con-
trol for variability in absorption rates after intraperito-
neal administration.
Instrumentation. A diagrammatic representation
of the system is shown in Figure 1. A water-filled micro-
needle was used to cannulate the eyes. To make the
microneedle, borosilicate glass (OD 1.0 mm, ID 0.58
mm; Sutter Instruments, Novato, CA) was pulled with
a pipette puller (Flaming Brown [Sutter Instru-
ments]), and the tip was cut at an outer diameter
of 50 (j,m using a microforge (DeFonbrune, General
Scientific, Redhill Surrey, England). The tip was then
beveled to 45° with a microgrinder (Narishige, Tokyo,
Japan) and sharpened on a microforge. The micro-
needle was connected to a DTX pressure transducer
(Viggo Spectramed, Oxnard, CA). The pressure trans-
ducer relayed its signal to a PM1000 amplifier (CWE,
Inc, Ardmore, PA) that was connected to a DI200 data
acquisition card (Dataq Instruments) and a computer.
Windaq data acquisition and playback software (Dataq
Instruments, Akron, OH) were used to collect and
analyze the data. Before measurement, the system was
calibrated by use of a mercury manometer.
Validation. To validate this system over a range of
pressures, one investigator randomly varied the IOP
up and down between 1 and 45 mm Hg by use of a
water-filled micrometer syringe connected to the eye
and to a water-filled manometer (Fig. IB). This investi-
gator could not see the computer reading generated
by a pressure transducer, which was connected to the
same eye independent of the water manometer. A
second investigator, who could not see the manometer
reading, recorded the transducer-generated pressure.
One hundred twenty readings were obtained in six
mice (20 per eye). To determine whether IOP is al-
tered on entering the eye, a duplicate measurement
system was constructed. Intraocular pressure measure-
ment was performed as usual, except that the micro-
needle was left in the anterior chamber after a pres-
sure reading was obtained. The microneedle of the
second system was inserted into the anterior chamber.
The pressure recorded by the second microneedle was
compared to the reading obtained before its insertion.
Intraocular Pressure Measurement. As soon as the
mice were anesthetized sufficiently, they were placed
on a surgical platform and were immobilized with
stainless steel head and leg holders. When manipulat-
ing the animals, we were careful to avoid pressure on
the neck that could alter IOP. A drop of phosphate-
buffered saline (PBS) was placed on each eye to pre-
vent corneal dehydration and to alter refraction and
allow a clear view into the anterior chamber. The left
eye was viewed under a dissecting microscope, and
the microneedle tip was placed inside its drop of PBS.
At this point, the pressure reading was zeroed. The














FIGURE l. A diagrammatic representation of the equipment vised to measure and adjust
intraocular pressure.
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chamber by piercing the cornea over the pupil. The
microneedle was located precisely in the anterior
chamber by use of a micromanipulator, on which it
was mounted. The microneedle tip usually rested 50
fj,m to 100 fim into the chamber. Sometimes, however,
the tip penetrated to approximately 250 fim to 300
fim and touched the lens. When this happened, the
tip was retracted to a depth of 50 (j,m to 100 /um. Care
was taken to minimize corneal deformation and to
ensure that the eye remained in its normal position.
The IOP was recorded at 30-second intervals for the
first 2 minutes after ocular entry. These readings were
averaged to determine the IOP of each animal. To
confirm microneedle patency, gentie pressure was ap-
plied to the eyelid. A prompt increase in pressure
was required for the inclusion of data. Carefully, the
microneedle was withdrawn from the anterior cham-
ber so that the tip was located in the drop of PBS.
Rapid return of the pressure to zero was required for
the inclusion of data. Before administering anesthesia
to the next animal, the microneedle was flushed with
sterile water. Procedures were similar in experiments
involving the insertion of two microneedles. If pene-
tration of the cornea was difficult and involved pro-
longed pushing (difficult entries), the data were dis-
carded because the IOP may have been artificially low.
Inclusion of data also required that an eye have mini-
mal or no leakage. An eye was regarded as leaky if
IOP readings dropped rapidly or consistently over the
measurement period.
Slit Lamp Biomicroscopy. Pupils were dilated with
a drop of 1 % atropine sulfate, and eyes were viewed
through a Nikon (Tokyo, Japan) biomicroscope. Eyes
were analyzed at 1, 2, 6, and 8 weeks after IOP was
measured.
50-r y= -0.54 + 0.98x




FIGURE 2. Scatterplot of manometrically set intraocular pres-
sure (IOP) against transducer-generated IOP readings. The
relationship between manometrically set IOP and trans-
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FIGURE 3. Intraocular pressure in male mice 9 to 11 weeks
of age. Strain means were compared by a Student's <-test.
The difference between strains C3H and B6 was not signifi-
cant (P > 0.1). Other strain comparisons were as follows:
*A/J versus BALB, ffA/J versus B6, JA/J versus C3H, §BALB
versus C3H, and ||BALB versus B6.
RESULTS. Validation and Success Rate. The re-
ported system accurately measured the pressure
(transducer pressure) in mouse eyes set at various
pressures by use of a micrometer syringe and a water
manometer (Fig. 2). Duplicate measurement systems
were used to assess the effect of microneedle insertion.
The pressure recorded on the first microneedle
(IOP1), before insertion of the second microneedle,
was compared to the pressure recorded through die
second microneedle (IOP2). The process of inserting
a microneedle into the anterior chamber did not sig-
nificantly alter IOP. The mean difference between
IOP1 and IOP2 was -0.3 ± 0.2 mm Hg (P > 0.1
for comparison of IOP1 and IOP2 by paired f-test).
Corneal penetrations usually were uncomplicated;
there was minimal leakage around die needle and
often no detectable leakage at all. The average change
in IOP for 15 eyes was —0.5 ± 0.1 mm Hg (median,
—0.45 mm Hg) over the measurement period. We
successfully measured IOP in 79% of the mice.
Intraocular Pressure. Figure 3 shows the intraocu-
lar pressure readings (mean ± SEM) of male mice of
each strain. Strain means were compared by Student's
Rest, and significant inters train differences were
found. Strains C3H and B6 have the highest pressures
(13.7 ± 0.8 mm Hg and 12.3 ± 0.5 mm Hg, respec-
tively). A/J is intermediate (9.4 ± 0.5 mm Hg), and
BALB is the lowest (7.7 ± 0.5 mm Hg). All means
except for C3H and B6 were significandy different.
Ocular Consequences. Very fine microneedles
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damage the eye minimally. On needle removal, many
eyes leaked but recovered quickly. Animals were moni-
tored closely during the recovery period, and none
showed any symptoms of distress (such as scratching
or blepharospasm). Gross examination of the eyes re-
vealed no damage 1 day after IOP measurement. Slit
lamp examination identified a small scar (often not
visible until pupil dilation) where the microneedle
penetrated the cornea. In some animals, the micro-
needle touched the lens as it entered the eye, occa-
sionally causing a small opaque spot on the lens. Every-
thing else appeared normal by gross and slit lamp
examination at 1, 2, 6, and 8 weeks after measurement.
DISCUSSION. We have developed and validated
an accurate and reliable method to measure IOP in
mice. To assess our system's ability to measure un-
known IOP, we randomly varied IOP between 0 and
45 mm Hg and obtained transducer-generated read-
ings in a "blinded" fashion. The close relationship
between manometer and transducer readings (T2 =
0.98) shows that the system accurately measures rau-
rine IOP over the tested range (Fig. 2). The effect of
introducing the microneedles into the anterior cham-
bers was evaluated by determining IOP with one mi-
croneedle and then observing the effect of inserting
a second microneedle. Results show that microneedle
insertion has only a minor effect on IOP (lowering it
by 0.3 mm Hg on average) over the pressure range
tested. The reliability of our procedure is demon-
strated by the successful ascertainment of IOP in 79%
of the experimental animals.
Using this system, we identified IOP differences
between different inbred strains of mice (Fig. 3). Be-
cause these age- and sex-matched mice were main-
tained in virtually identical environments and were
fed the same diet, these IOP differences probably were
caused by interstrain genetic differences. The ability
to measure genetically determined differences in IOP
provides further evidence that this procedure is accu-
rate and performs well in an experimental setting. In
addition, it indicates that this method can be used in
studies to map genes that contribute to IOP differ-
ences between various strains of mice.
The microneedle causes little visible damage to
the analyzed eye, and animals exhibit no signs of pain
or distress from it. Nevertheless, there are limitations
to this invasive procedure for IOP evaluation. For ex-
ample, the required use of anesthesia could alter IOP.
For our analyses, we used a combination of ketamine
and xylazine. Many anesthetic agents, including xylaz-
ine, lower IOP. Ketamine usually appears to increase
IOP,0"8 but there are reports of ketamine having no
effect on IOP or even reducing IOP.see 6'9 Different
doses or different routes of administration may con-
tribute to these differences. Few studies have assessed
the physiological consequences of a mixture of keta-
mine and xylazine during the first 20 minutes after
the administration of anesthesia. (In our experiments,
IOP measurement usually was completed by 11 min-
utes after the administration of anesthesia.) Similarly,
few studies have assessed these consequences after in-
traperitoneal administration (the preferred route of
administration in mice), which usually takes longer
to affect an animal's physiological status than direct
intravenous or intramuscular injection. In one study,
the effects of intravenous administration of ketamine
and xylazine were evaluated in horses at 2-minute in-
tervals until the animals started to wake (approxi-
mately 16 to 18 minutes after injection). Anesthesia
had no significant effect on IOP.10 This experiment
was similar to ours because the mice woke from their
dose of ketamine and xylazine between 15 and 20
minutes after injection. In another study, the effects of
intraperitoneally administered ketamine and xylazine
were evaluated in rats (we used the intraperitoneal
route in mice). Anesthesia had a minor effect on
blood pressure during the first 15 minutes after injec-
tion, but it had a strong hypotensive effect between
15 and 30 minutes that continued for more than 1
hour.11 These experiments suggest that a combination
of ketamine and xylazine causes relatively minor physi-
ologic changes during the 15-minute interval immedi-
ately after the intraperitoneal administration of anes-
thesia (the time frame of all our IOP measurements).
Supporting this is our unpublished observation that
there was no significant difference in IOP between
mice evaluated between 5 and 18 minutes after injec-
tion of our standard dose of these agents. Another
drawback of our invasive method to measure IOP is
the difficulty in interpreting repeated measurements
in an eye after drug therapy because the microneedle
may cause some inflammation and because aqueous
humor often leaks from the eye on microneedle re-
moval. These factors could alter aqueous humor dy-
namics for an unknown period of time. This is not a
serious problem for genetic studies. Valuable data can
be obtained from a single measurement in a number
of genetically similar animals. In age-matched groups
of animals that differ only in the presence or absence
of a single mutation, IOP assessment can define the
effects the mutation has on IOP. To determine the
effects of the mutation on IOP with relation to age,
different similarly matched groups of animals can be
evaluated at different ages. A noninvasive method
would be advantageous, however, and would allow re-
peated measurements on a single eye. A noninvasive
measurement system would be more useful for investi-
gating the effect of age, drugs, or other factors on
IOP with time. Human tonometers have been used
successfully to measure IOP in rats.1213 We have at-
tempted to use both the Tono-Pen XL (Mentor, Santa
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Barbara, CA) and the ProTon Tonometer (Tomey
Technology, Cambridge, MA) on mice. In our hands,
these instruments could not reproducibly measure
IOP in the very small eyes of mice. We are working
toward the development of a noninvasive tonometer
for mouse eyes. Our current procedure will allow cali-
bration and validation of future noninvasive instru-
ments.
In summary, we have developed and validated a
system that accurately measures IOP in mouse eyes.
We have used this system to identify IOP differences
between genetically distinct strains of mice. This work
will facilitate studies on IOP and glaucoma in mice.
These future studies will complement studies in hu-
mans and other species and will add considerably to
a genetic understanding of glaucoma.
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Topical Corticosteroids Reverse the
Antiviral Effect of Topical Cidofovir
in the Ad5-Inoculated New Zealand
Rabbit Ocular Model
Eric G Romanowski, Trinita Araullo-Cruz,
and Y. Jerold Gordon
Purpose. To determine how the addition of topical corti-
costeroids would affect the anti-adenoviral inhibitory
effect of topical cidofovir (S-HPMPC) in the Ad5 New
Zealand (Ad5/NZ) rabbit ocular model.
Methods. In a series of experiments (two-eye design),
Ad5-inoculated/NZ rabbits (10° pfu/eye) were treated
with 1 of 3 treatment regimens. Group 1 was adminis-
tered 1% cidofovir (CDV) twice a day for 3 days plus
comfort tears four times a day for 14 days. Group 2 was
administered 1% CDV twice a day for 3 days plus 1%
Pred Forte four times a day for 14 days. Group 3 was
administered vehicle twice a day for 3 days plus comfort
tears four times a day for 14 days and served as the
control. All eyes were evaluated for 21 days for serial eye
titers, Ad5 positive eyes, and duration of Ad5 shedding.
Results. Compared to control eyes in the Ad5/NZ rabbit
ocular model, CDV alone demonstrated a significant
antiviral inhibitor)' effect: reduced mean Ad5 eye titer
during the early phase of infection (days 3 to 7), fewer
Ad5-positive eyes during the early and late (days 9 to
21) phases of infection, and shortened duration of
shedding. However, concomitant treatment with both
Pred Forte and CDV significantly reversed the antiviral
